KALA CIK: 1479419

KALA BIO, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
124
FY22:
85.9
FY23:
52.9
FY24:
52.8
FY25:
9.49
(positive)
Change from FY21 to FY25
millions USD
FY21:
15.1
FY22:
0.88
FY23:
3.08
FY24:
2.69
FY25:
0
Total assets
Change from FY21 to FY25
millions USD
FY21:
139
FY22:
86.8
FY23:
55.9
FY24:
55.5
FY25:
9.49

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
37.4
FY22:
25.7
FY23:
8.35
FY24:
17.0
FY25:
2.49
(negative)
Change from FY21 to FY25
millions USD
FY21:
85.2
FY22:
42.2
FY23:
40.1
FY24:
26.2
FY25:
0
(positive)
Change from FY21 to FY25
millions USD
FY21:
16.8
FY22:
19.0
FY23:
7.50
FY24:
12.3
FY25:
7.00
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
139
FY22:
86.8
FY23:
55.9
FY24:
55.5
FY25:
9.49

All amounts in millions USD Data source:SEC EDGAR